Hearing loss (HL) and chronic kidney disease (CKD) are conditions with high prevalence worldwide. Patients with oto-renal disorders are reported to have both syndromic forms of HL and kidney dysfunction due to common molecular signaling pathways. The major shared genetic factors, common developmental pathways, and physiological mechanisms adversely affect the auditory and kidney systems. This review consolidates the common morphogenic origins of the kidney and the cochlea, which focus on the major shared genes, networks, and oto-renal disorders that affect the cilia, collagen networks, and transport channels in both systems. This article shines a spotlight on mechanisms and pathophysiology of the major congenital disorders causing HL and kidney diseases. In addition to this, other risk factors including hemodialysis and certain drugs increase the risk of HL in patients with CKD. This review can help clinicians navigate options for differential diagnosis of oto-renal disorders. An interdisciplinary approach across nephrologists, audiologists, pediatricians, and geneticists can pave the way for effective screening, diagnosis, and treatment interventions. This also underscores the importance of future research on the ear–kidney axis to understand molecular signaling, biomarker discovery, and clinical management.
Disease severity in acute pancreatitis requires proper assessment at an early stage to ensure proper triage, management, and prognostication. Various clinical scoring systems that are based on laboratories are highly used in severity stratification, such as Ranson criteria, Bedside Index of Severity in Acute Pancreatitis (BISAP), and Acute Physiology and Chronic Health Evaluation II (APACHE II). Nonetheless, the scores depend on indirect physiological and biochemical parameters and can not be predictive of the degree of local pancreatic damage. The CT Severity Index (CTSI) using Balthazar scoring, which is a direct anatomical evaluation tool, is specifically used to evaluate the disease with contrast-enhanced computer tomography (CECT) and can be a better prognostic tool. The proposed research project is observational in nature, and the proposed tertiary care teaching hospital will be used to identify 100 adult patients who presented with acute pancreatitis. Clinical assessment, lab tests, Ranson, BISAP, APACHE II scores, and CECT abdomen to evaluate CTSI were done in all patients. Follow-up of patients during hospital stay was done to record local and systemic complications, intensive care unit (ICU) admission, length of stay in the hospital and death. The comparison between clinical scoring systems and CTSI was conducted through statistical analysis to determine the predictive performance of the system. The most prevalent aetiology was the alcohol, and then the gallstone disease. Clinical scoring systems diagnosed most of the patients with mild to moderate disease, but CTSI diagnosed more patients with moderate to severe pancreatitis. CTSI showed high correlation with local complications, ICU hospitalisation, extended hospitalisation, and death, in contrast with the laboratory-based scoring systems. Irrationalities were also noted where the clinical scores of the patient deemed mild had a severe disease severity on the CECT. The CT Severity Index based on CECT proved to be more accurate in determining the severity of the disease and prognosis in cases of acute pancreatitis than the traditional clinical scoring systems based on laboratory. Imaging severity assessment must be regarded as a part and parcel of the entire assessment in patients with acute pancreatitis.
Background MicroRNAs (miRNAs) are a class of small endogenous RNAs to regulate cell function and fate. Drosha, the nuclease to process pri-miRNAs to pre-miRNAs, is a key molecule to the biogenesis of miRNAs. The critical mutations in the DROSHA sequence to affect miRNA maturation remain largely unknown. Thus, we used in silico algorithms, protein-protein docking (PPD), molecular dynamics (MD) simulation, and experimental studies to determine and characterize the role of single nucleotide polymorphism of (SNPs) of the Drosha gene in the mouse vascular smooth muscle cells (VSMCs). Methods Different in silico algorithms, including SIFT, PROVEAN, I-Mutant 2.0, SNAP and PANTHER were used to predict the mutations on Drosha. Then, we characterized the binding efficiency of mutated DROSHA with Dgcr8 using PPD and MD simulations. Further, we mutated that potential site on Drosha to mouse vascular smooth muscle cells (VSMCs) and determined its cellular role in miR-16 and miR-21 maturation. Results All the selected algorithms indicated that the deleterious nonsynonymous SNPs in site 401 (E401Q) on DROSHA are a potential mutation region. The results of binding affinity, RMSD, RMSF, and radiation of gyrus indicated expressed that the changes in a glutamic acid to glutamine of Drosha may alter miRNA maturation through Dgcr8. After the over-expression of mutant Drosha in the mouse VSMCs, the expressions of the anti-tumor miR-16 and the oncogenic miR-21, the two most highly expressed miRNAs in VSMC, were significantly down-regulated. It is also noted that the expression of miR-21 had a greater decrease than that of miR-16 by the mutation, suggesting the E401Q might be helpful to attenuate the oncogenic miR-21 production. Conclusions Our data, for the first time, disclose the role of the E401Q on DROSHA in mouse VSMCs.
Down syndrome (trisomy 21) is associated with immune dysregulation and an increased prevalence of both autoimmune and non-immunological dermatological disorders. Early recognition of these cutaneous manifestations facilitates timely diagnosis and appropriate management. Four patients with Down syndrome presenting with distinct dermatological conditions were evaluated. The first case involved alopecia areata associated with lichen nitidus, while the second demonstrated the ophiasis variant of alopecia areata. The third case was diagnosed as dermatitis neglecta, confirmed by complete removal of hyperpigmented plaques with saline-soaked gauze. The fourth case presented with hidradenitis suppurativa and a giant multinodular keloid over the occipital scalp, likely secondary to acne keloidalis nuchae, representing a rare association. These cases underscore the immune dysregulation-related predisposition to autoimmune and inflammatory dermatoses, as well as non-immunological conditions related to hygiene and skin fragility, in individuals with Down syndrome. Awareness of this broad spectrum, combined with regular dermatological screening, is essential for timely diagnosis, appropriate management, and improved quality of life in this population. Keywords: Down syndrome; Trisomy 21; Alopecia areata; Lichen nitidus; Hidradenitis suppurativa; Keloid; Acne keloidalis nuchae; Dermatitis neglecta
To enhance therapeutic results, targeted nanoparticle distribution in cervical cancer treatment demands extreme accuracy and optimal decision-making. In order to improve prediction accuracy and delivery productivity, this study suggests a hybrid Genetic Algorithm–Convolutional Neural Network (GA–CNN) model. While the Genetic Algorithm improves hyperparameters and feature selection for better performance, the CNN component efficiently extracts intricate spatial and biological information from medical data. The suggested model is compared to conventional machine learning methods such as Random Forest, Support Vector Machine, and Logistic Regression. With an accuracy of 96.5% and an AUC of 97.8%, experimental data show that the GA–CNN hybrid model performs significantly improved than current models. Better targeting and fewer computing wastage are made possible by the combination of deep learning with optimization. This method contributes to better diagnostic and treatment planning in cervical cancer nanoparticle delivery systems by providing a dependable and scalable precision medicine solution.